Showing results (161-170 of 1,551) with videos related to

Sort By:
Pageof 156
JCO Oncology Practice|June 16, 2021
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed TherapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
JCO Oncology Practice|December 10, 2020
Management of Advanced Prostate Cancer in Clinical Practice: Real-World Answers to Challenging DilemmasNataliya Mar, Arash Rezazadeh Kalebasty, Edward M Uchio
JCO Oncology Practice|April 14, 2023
A Three-Step Taxane Titration Protocol Decreases Hypersensitivity Reactions During First and Second ExposuresDonna-Marie Lynch, Susanne Menon, Emanuele Mazzola, et al.
JCO Oncology Practice|April 18, 2023
Current Trends in the Utilization of Preoperative Breast Magnetic Resonance Imaging Among Women With Newly Diagnosed Breast CancerI-Wen Pan, Tina W F Yen, Isabelle Bedrosian, et al.
JCO Oncology Practice|April 19, 2023
Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung CancerAvani M Singh, Rafael Rubiera-Pebe, Yaser Ahmad, et al.
JCO Oncology Practice|April 8, 2021
Understanding Active Surveillance for Prostate CancerLillian Y Lai, Vahakn B Shahinian, Mary K Oerline, et al.
JCO Oncology Practice|July 30, 2020
ASCO Quality Training Program: A Five-Year ReviewMichael Keng, Doris Quinn, Gene Cunningham, et al.
JCO Oncology Practice|August 8, 2020
Illness Understanding, Prognostic Awareness, and End-of-Life Care in Patients With GI Cancer and Malignant Bowel Obstruction With Drainage Percutaneous Endoscopic GastrostomyJessica I Goldberg, Debra A Goldman, Sarah McCaskey, et al.
JCO Oncology Practice|April 1, 2021
Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness AnalysisEdward Li, Dylan J Mezzio, David Campbell, et al.
JCO Oncology Practice|August 5, 2020
Conducting Goals-of-Care Discussions Takes Less Time Than ImaginedSofya Pintova, Ryan Leibrandt, Cardinale B Smith, et al.
Pageof 156